rdge44 thanks for the kind words. When it comes to MS, I think that there may be hope. Last week literally millions of shares were bought in just a few days. Buying continued through the first half of Thursdays trading, and then stopped. Since then, volume has been light, and the stock has been dropping. I would guess that the people that were doing the buying have bought all that they wanted. But the point is that MILLIONS of shares were bought and that wouldn't have taken place if something major hadn't happened. Like outstanding results already in the patients that have started the drug trials.
All that buying for day after day must mean that at least several, or more, people in the know must have seen something that really impressed them. If it was just one person that was behind the buying it wouldn't have gone on for days.
It may be that it was people in management that were startled with something they saw and jumped in before the results were announced.
Management has previously been buying shares, but not in such big amounts, and not for day after day.
NerveGen's drug lets the body repair damaged, and even severed neurons. This would include neurons that have been damaged from multiple sclerosis. However, multiple sclerosis is caused by a person's immune system
attacking the myelin sheath of the brain's neurons.
NerveGen's drug may not stop that, but it could be used along with drugs such as Ibudilast that counteract the immune response.
But my point is that last week's trading could indicate that there has been an indication that the people that have been dosed with our drug have had some good indication that it is (very) effective. Even if this isn't the reason for the stock's rise. Over the longer term, I think that the drug will prove its effectiveness.
Good luck to you and your family.